Atlas Trials

A Single Ascending Dose Study of ACT-541468 in Healthy Male Subjects

Clinical trial NCT02919319 · COMPLETED

Trial details

NCT number
NCT02919319
Sponsor
Idorsia Pharmaceuticals Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2015-02-01
Primary completion
2015-05-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.